Trial Profile
A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Acarbose/metformin (Primary) ; Acarbose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 26 Sep 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 26 Sep 2013 Status changed from recruiting to completed.